Log in

Wugen Appoints New Vice President and Head of NK Research as the Company Continues to Expand its Pipeline

By Wugen Inc.
Posted 11/19/20

ST. LOUIS, Nov. 19, 2020 /PRNewswire/ -- Wugen Inc., a biotechnology company developing a novel, universal allogeneic CAR-T therapy platform, today announced the appointment of Ryan Sullivan, …

This item is available in full to subscribers.

Please log in to continue

Log in